Connection

ABDI RASEKH to Humans

This is a "connection" page, showing publications ABDI RASEKH has written about Humans.
Connection Strength

0.299
  1. Medical and Device Therapy for Stroke Prevention in Patients With Atrial Fibrillation. Tex Heart Inst J. 2021 Sep 01; 48(4).
    View in: PubMed
    Score: 0.020
  2. Left Atrial Appendage Closure and Pulmonary Vein Isolation. Tex Heart Inst J. 2020 02; 47(1):60-62.
    View in: PubMed
    Score: 0.017
  3. Thromboembolism in Atrial Fibrillation: Role of the Left Atrial Appendage. Card Electrophysiol Clin. 2020 03; 12(1):13-20.
    View in: PubMed
    Score: 0.017
  4. Closure of Left Atrial Appendage to Prevent Stroke: Devices and Status. Tex Heart Inst J. 2018 06; 45(3):172-174.
    View in: PubMed
    Score: 0.016
  5. Update on Atrial Fibrillation. Tex Heart Inst J. 2016 Oct; 43(5):412-414.
    View in: PubMed
    Score: 0.014
  6. Where We Stand on Left Atrial Appendage Closure for Stroke Prevention in Atrial Fibrillation. Tex Heart Inst J. 2016 Aug; 43(4):320-3.
    View in: PubMed
    Score: 0.014
  7. Differences in experience with a new delivery device for LAA ligation among various U.S. centers. J Am Coll Cardiol. 2015 Feb 03; 65(4):404-405.
    View in: PubMed
    Score: 0.012
  8. Initial experience with a novel percutaneous left atrial appendage exclusion device in patients with atrial fibrillation, increased stroke risk, and contraindications to anticoagulation. Am J Cardiol. 2013 Mar 15; 111(6):869-73.
    View in: PubMed
    Score: 0.011
  9. Biventricular intracardiac device implanted in a patient with persistent left superior vena cava. Tex Heart Inst J. 2012; 39(4):586-7.
    View in: PubMed
    Score: 0.010
  10. Stroke prevention in nonvalvular atrial fibrillation. Tex Heart Inst J. 2011; 38(4):350-2.
    View in: PubMed
    Score: 0.009
  11. Catheter-based ablation of atrial fibrillation: a brief overview. Tex Heart Inst J. 2011; 38(4):361-3.
    View in: PubMed
    Score: 0.009
  12. Stent-graft exclusion of multiple symptomatic coronary artery fistulae. Tex Heart Inst J. 2007; 34(2):199-202.
    View in: PubMed
    Score: 0.007
  13. Electrophysiology: catheter ablation of atrial fibrillation. Tex Heart Inst J. 2006; 33(2):190-1.
    View in: PubMed
    Score: 0.007
  14. Electrocardiographic P-wave parameters and lifetime atrial fibrillation risk: A multicohort study. Heart Rhythm. 2026 Feb; 23(2):332-339.
    View in: PubMed
    Score: 0.006
  15. Anticoagulants and atrial fibrillation. Tex Heart Inst J. 2005; 32(2):218-9.
    View in: PubMed
    Score: 0.006
  16. Mortality in Recipients of Durable Left Ventricular Assist Devices Undergoing Ventricular Tachycardia Ablation. JACC Clin Electrophysiol. 2024 Sep; 10(9):2049-2058.
    View in: PubMed
    Score: 0.006
  17. Incidence, Risk Score Performance, and In-Hospital Outcomes of Postoperative Atrial Fibrillation After Cardiac Surgery. Tex Heart Inst J. 2023 10 25; 50(5).
    View in: PubMed
    Score: 0.006
  18. Detection of atrial fibrillation in real world setting in patients with cryptogenic stroke and an implantable loop recorder. Pacing Clin Electrophysiol. 2023 07; 46(7):788-795.
    View in: PubMed
    Score: 0.006
  19. Risk Stratification in Patients Who Underwent Percutaneous Left Atrial Appendage Occlusion. Am J Cardiol. 2023 08 01; 200:50-56.
    View in: PubMed
    Score: 0.006
  20. Slow-pathway visualization by using voltage-time relationship: A novel technique for identification and fluoroless ablation of atrioventricular nodal reentrant tachycardia. J Cardiovasc Electrophysiol. 2020 06; 31(6):1430-1435.
    View in: PubMed
    Score: 0.004
  21. Exclusion of electrical and mechanical function of the left atrial appendage in patients with persistent atrial fibrillation: differences in efficacy and safety between endocardial ablation vs epicardial LARIAT ligation (the EXCLUDE LAA study). J Interv Card Electrophysiol. 2020 Apr; 57(3):409-416.
    View in: PubMed
    Score: 0.004
  22. Long-term clinical outcomes from real-world experience of left atrial appendage exclusion with LARIAT device. J Cardiovasc Electrophysiol. 2019 12; 30(12):2849-2857.
    View in: PubMed
    Score: 0.004
  23. Epicardial Left Atrial Appendage Exclusion Reduces Blood Pressure in?Patients With Atrial Fibrillation and?Hypertension. J Am Coll Cardiol. 2018 09 18; 72(12):1346-1353.
    View in: PubMed
    Score: 0.004
  24. Anatomical and electrical remodeling with incomplete left atrial appendage ligation: Results from the LAALA-AF registry. J Cardiovasc Electrophysiol. 2017 Dec; 28(12):1433-1442.
    View in: PubMed
    Score: 0.004
  25. Subcutaneous Versus Transvenous Implantable Defibrillator Therapy: A Meta-Analysis of Case-Control Studies. JACC Clin Electrophysiol. 2017 12 26; 3(13):1475-1483.
    View in: PubMed
    Score: 0.004
  26. Anesthetic Management of Patients Undergoing Percutaneous Endocardial and Epicardial Left Atrial Appendage Occlusion. Semin Cardiothorac Vasc Anesth. 2017 Dec; 21(4):291-301.
    View in: PubMed
    Score: 0.004
  27. Accuracy of Voltage Signal Measurement During Radiofrequency Delivery Through the SMARTTOUCH Catheter. J Cardiovasc Electrophysiol. 2017 01; 28(1):51-55.
    View in: PubMed
    Score: 0.003
  28. Conversion of persistent atrial fibrillation to sinus rhythm after LAA ligation with the LARIAT device. Int J Cardiol. 2016 Dec 15; 225:120-122.
    View in: PubMed
    Score: 0.003
  29. Short and long-term outcomes of percutaneous left atrial appendage suture ligation: Results from a US multicenter evaluation. Heart Rhythm. 2016 05; 13(5):1030-1036.
    View in: PubMed
    Score: 0.003
  30. Impact of Periprocedural Colchicine on Postprocedural Management in Patients Undergoing a Left Atrial Appendage Ligation Using LARIAT. J Cardiovasc Electrophysiol. 2016 Jan; 27(1):60-4.
    View in: PubMed
    Score: 0.003
  31. Differences in complication rates between large bore needle and a long micropuncture needle during epicardial access: time to change clinical practice? Circ Arrhythm Electrophysiol. 2015 Aug; 8(4):890-5.
    View in: PubMed
    Score: 0.003
  32. Left atrial thrombus formation after successful left atrial appendage ligation: case series from a nationwide survey. J Am Coll Cardiol. 2015 Apr 21; 65(15):1595-6.
    View in: PubMed
    Score: 0.003
  33. Endocardial (Watchman) vs epicardial (Lariat) left atrial appendage exclusion devices: Understanding the differences in the location and type of leaks and their clinical implications. Heart Rhythm. 2015 Jul; 12(7):1501-7.
    View in: PubMed
    Score: 0.003
  34. Safety and effectiveness of compassionate use of LARIAT? device for epicardial ligation of anatomically complex left atrial appendages. J Interv Card Electrophysiol. 2015 Jan; 42(1):11-9.
    View in: PubMed
    Score: 0.003
  35. Cryoballoon pressure waveform change during balloon inflation is not a reliable predictor of adequate pulmonary vein occlusion. Pacing Clin Electrophysiol. 2014 Dec; 37(12):1702-7.
    View in: PubMed
    Score: 0.003
  36. Impact of left atrial appendage exclusion using an epicardial ligation system (LARIAT) on atrial fibrillation burden in patients with cardiac implantable electronic devices. Heart Rhythm. 2015 Jan; 12(1):52-9.
    View in: PubMed
    Score: 0.003
  37. Phased RF ablation in persistent atrial fibrillation. Heart Rhythm. 2014 Feb; 11(2):202-9.
    View in: PubMed
    Score: 0.003
  38. Exclusion of the left atrial appendage to prevent stroke in cases of atrial fibrillation. Tex Heart Inst J. 2012; 39(4):535-7.
    View in: PubMed
    Score: 0.002
  39. Transseptal biopsy of a left atrial mass with 3-dimensional transesophageal echocardiographic guidance. Tex Heart Inst J. 2012; 39(5):707-10.
    View in: PubMed
    Score: 0.002
  40. Implantation success and infection in cardiovascular implantable electronic device procedures utilizing an antibacterial envelope. Pacing Clin Electrophysiol. 2011 Feb; 34(2):133-42.
    View in: PubMed
    Score: 0.002
  41. Tachycardia-mediated cardiomyopathy and the permanent form of junctional reciprocating tachycardia. Tex Heart Inst J. 2010; 37(6):695-8.
    View in: PubMed
    Score: 0.002
  42. Variability in postpacing intervals predicts global ventricular activation pattern during tachycardia. Pacing Clin Electrophysiol. 2010 Feb; 33(2):129-34.
    View in: PubMed
    Score: 0.002
  43. Cardiac resynchronization therapy in patients with right ventricular pacing-induced cardiomyopathy. Pacing Clin Electrophysiol. 2010 Jan; 33(1):37-40.
    View in: PubMed
    Score: 0.002
  44. Arrhythmogenicity of weight-loss supplements marketed on the Internet. Heart Rhythm. 2009 May; 6(5):658-62.
    View in: PubMed
    Score: 0.002
  45. Coalescence of splines on a basket mapping catheter during ablation using a closed-loop irrigation catheter. Europace. 2009 Feb; 11(2):258-9.
    View in: PubMed
    Score: 0.002
  46. Cardiac resynchronization therapy may improve symptoms of congestive heart failure in patients without electrical or mechanical dyssynchrony. Europace. 2009 Jan; 11(1):86-8.
    View in: PubMed
    Score: 0.002
  47. Organized incessant atrial arrhythmias in the setting of severe, isolated biatrial scarring. Pacing Clin Electrophysiol. 2008 Jun; 31(6):666-75.
    View in: PubMed
    Score: 0.002
  48. Variability in post-pacing intervals predicts global atrial activation pattern during tachycardia. J Cardiovasc Electrophysiol. 2008 Feb; 19(2):142-7.
    View in: PubMed
    Score: 0.002
  49. Interatrial conduction measured during biventricular pacemaker implantation accurately predicts optimal paced atrioventricular intervals. J Cardiovasc Electrophysiol. 2007 Mar; 18(3):290-5.
    View in: PubMed
    Score: 0.002
  50. The effects of pulmonary vein isolation on the dominant frequency and organization of coronary sinus electrical activity during permanent atrial fibrillation. Pacing Clin Electrophysiol. 2006 Nov; 29(11):1201-8.
    View in: PubMed
    Score: 0.002
  51. Slow pathway ablation decreases vulnerability to pacing-induced atrial fibrillation: Possible role of vagal denervation. Pacing Clin Electrophysiol. 2006 Nov; 29(11):1234-9.
    View in: PubMed
    Score: 0.002
  52. Chest pain and diaphragmatic pacing after pacemaker implantation. Tex Heart Inst J. 2005; 32(1):106-7.
    View in: PubMed
    Score: 0.002
  53. Postoperative atrial fibrillation and mortality after coronary artery bypass surgery. J Am Coll Cardiol. 2004 Mar 03; 43(5):742-8.
    View in: PubMed
    Score: 0.001
  54. Inappropriate shock delivery and biventricular pacing cardiac defibrillators. Tex Heart Inst J. 2003; 30(1):45-9.
    View in: PubMed
    Score: 0.001
  55. Pacemaker lead entrapment syndrome. Tex Heart Inst J. 2003; 30(1):84-5.
    View in: PubMed
    Score: 0.001
  56. Rapid ventricular tachycardias associated with cilostazol use. Tex Heart Inst J. 2002; 29(2):140-2.
    View in: PubMed
    Score: 0.001
  57. Cryoablation of incessant ventricular tachycardia: case report and long-term follow-up. Tex Heart Inst J. 2000; 27(1):52-4.
    View in: PubMed
    Score: 0.001
  58. Predictors of conversion to sinus rhythm using ibutilide for atrial fibrillation or flutter. Am J Cardiol. 2000 Jan 01; 85(1):112-4, A9.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.